Arcutis Biotherapeutics, Inc.
ARQT · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$140,039 | -$262,140 | -$311,458 | -$206,356 |
| Dep. & Amort. | $2,599 | $1,521 | $934 | $454 |
| Deferred Tax | $0 | $0 | $0 | $3,454 |
| Stock-Based Comp. | $41,730 | $38,813 | $32,682 | $23,892 |
| Change in WC | -$15,080 | -$23,501 | -$10,175 | $3,620 |
| Other Non-Cash | -$1,368 | -$1,750 | $30,302 | $309 |
| Operating Cash Flow | -$112,158 | -$247,057 | -$257,715 | -$174,627 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$143 | -$428 | -$23,283 | -$995 |
| Net Acquisitions | $0 | $0 | $22,950 | $74,958 |
| Inv. Purchases | -$254,820 | -$225,840 | -$415,389 | -$292,508 |
| Inv. Sales/Matur. | $288,783 | $406,500 | $351,473 | $217,550 |
| Other Inv. Act. | -$5,000 | $0 | -$22,950 | -$74,958 |
| Investing Cash Flow | $28,820 | $180,232 | -$87,199 | -$75,953 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$100,000 | $0 | $125,000 | $73,987 |
| Stock Issued | $161,682 | $98,901 | $176,047 | $207,490 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,520 | $2,422 | $751 | $470 |
| Financing Cash Flow | $66,202 | $101,323 | $301,798 | $281,947 |
| Forex Effect | -$235 | -$50 | $0 | $0 |
| Net Chg. in Cash | -$17,371 | $34,448 | -$43,116 | $31,367 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $89,323 | $54,875 | $97,991 | $66,624 |
| End Cash | $71,952 | $89,323 | $54,875 | $97,991 |
| Free Cash Flow | -$112,301 | -$247,485 | -$280,998 | -$175,622 |